Gene · 6370
Papers1,976
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,976
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inflammatory protein signatures in individuals with obesity and metabolic syndrome. | Sci Rep | 2023 | 38092892 | PubTator, text mining | PubMed |
| Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC. | Front Oncol | 2023 | 38090482 | PubTator, text mining | PubMed |
| Screening for Circulating Inflammatory Proteins Does Not Reveal Plasma Biomarkers of Constant Tinnitus. | J Assoc Res Otolaryngol | 2023 | 38079022 | PubTator, text mining | PubMed |
| Thymic Epithelial Tumor and Immune System: The Role of Immunotherapy. | Cancers (Basel) | 2023 | 38067278 | PubTator, text mining | PubMed |
| Integrated multiplex network based approach reveled CC and CXC chemokines associated key biomarkers in colon adenocarcinoma patients. | Am J Cancer Res | 2023 | 38058831 | PubTator, text mining | PubMed |
| Chemokine- and chemokine receptor-based signature predicts immunotherapy response in female colorectal adenocarcinoma patients. | Sci Rep | 2023 | 38049474 | PubTator, text mining | PubMed |
| Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5). | Front Pharmacol | 2023 | 38026988 | PubTator, text mining | PubMed |
| Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma. | Front Pharmacol | 2023 | 38026978 | PubTator, text mining | PubMed |
| Enniatin A inhibits the chaperone Hsp90 and unleashes the immune system against triple-negative breast cancer. | iScience | 2023 | 38025772 | PubTator, text mining | PubMed |
| Acute irradiation causes a long-term disturbance in the heterogeneity and gene expression profile of medullary thymic epithelial cells. | Front Immunol | 2023 | 38022666 | PubTator, text mining | PubMed |
| The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors. | Biomark Res | 2023 | 38017494 | PubTator, text mining | PubMed |
| The Force-Dependent Mechanism of an Integrin α4β7-MAdCAM-1 Interaction. | Int J Mol Sci | 2023 | 38003252 | PubTator, text mining | PubMed |
| γδ T cells: origin and fate, subsets, diseases and immunotherapy. | Signal Transduct Target Ther | 2023 | 37989744 | PubTator, text mining | PubMed |
| Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations. | Front Immunol | 2023 | 37954590 | PubTator, text mining | PubMed |
| Prediction of disease severity using serum biomarkers in patients with mild-moderate Atopic Dermatitis: A pilot study. | PLoS One | 2023 | 37917786 | PubTator, text mining | PubMed |
| Research advances in mechanism of antiangiogenic therapy combined with immune checkpoint inhibitors for treatment of non-small cell lung cancer. | Front Immunol | 2023 | 37915579 | PubTator, text mining | PubMed |
| Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker. | Genes (Basel) | 2023 | 37895310 | PubTator, text mining | PubMed |
| Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease. | Biomedicines | 2023 | 37893204 | PubTator, text mining | PubMed |
| Comparative Analysis of Cytokine Profiles in Cerebrospinal Fluid and Blood Serum in Patients with Acute and Subacute Spinal Cord Injury. | Biomedicines | 2023 | 37893015 | PubTator, text mining | PubMed |
| Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma. | Aging (Albany NY) | 2023 | 37889539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6370/papers?page=9